Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-07-07
1981-11-03
Kyle, Deborah L.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
128653, 260112R, 260112B, 260122, 424 8, 424 9, 424 12, 424177, A61K 4900, A61K 4300, G01N 3348
Patent
active
042985900
ABSTRACT:
Described herein is the utilization of anti-Malignin TAG products to detect the presence of cancerous or malignant tumor cells. These TAG products attach preferentially to cancerous or malignant tumor cells in cell collections in vitro or in vivo and thus can be detected by any attached visible or other signal emitter.
REFERENCES:
Bogoch et al., Neuro. Chemical Research, vol. 4, No. 4, 1979, pp. 465-472.
Bogoch et al., The Lancet, May 15, 1979, p. 987.
Bogoch et al., Neurology, vol. 29, Apr. 1979, p. 584.
Bogoch et al., Trans. Am. Soc. Neurochem., vol. 10, No. 1, 1979, p. 78.
Robbins, Chem. Abs., vol. 66, 1967, p. 5073, Abs. No. 53896r.
Boegman, Chem. Abs., vol. 74, 1971, p. 188, Abs. No. 21392x.
Benda, J. Neurosurg., vol. 33, Sep. 1970, pp. 281-286.
Bogoch, Reprint from Handbook of Neurochem., vol. 1, 1969, pp. 75-92.
Kyle Deborah L.
Nucker Christine M.
LandOfFree
Detection of malignant tumor cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection of malignant tumor cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection of malignant tumor cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1064341